SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-019074
Filing Date
2021-04-16
Accepted
2021-04-16 06:02:25
Documents
6
Period of Report
2021-05-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A atha-def14a_20201231.htm DEF 14A 960924
2 GRAPHIC gtw5gx3pd5hy000001.jpg GRAPHIC 13134
3 GRAPHIC gtw5gx3pd5hy000005.jpg GRAPHIC 474504
4 GRAPHIC gtw5gx3pd5hy000003.jpg GRAPHIC 10364
5 GRAPHIC gtw5gx3pd5hy000002.jpg GRAPHIC 10364
6 GRAPHIC gtw5gx3pd5hy000004.jpg GRAPHIC 495561
  Complete submission text file 0001564590-21-019074.txt   2345231
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39503 | Film No.: 21830020
SIC: 2836 Biological Products, (No Diagnostic Substances)